Feb 9, 2026 08:00AM
Feb 5, 2026 06:30PM
Feb 5, 2026 06:30PM
Jan 14, 2026 08:25PM
Dec 17, 2025 08:00AM
Dec 9, 2025 06:06AM
Dec 9, 2025 06:06AM Ascentage Pharma reports phase III data for leukemia drug candidate
Dec 9, 2025 06:06AM
Dec 8, 2025 07:45PM
Dec 8, 2025 07:45PM
Dec 8, 2025 07:45PM
Dec 7, 2025 08:10PM
Dec 6, 2025 10:15AM
Dec 4, 2025 07:00PM Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA
Dec 1, 2025 08:00AM
Nov 24, 2025 07:00PM
Nov 19, 2025 08:00AM
Nov 3, 2025 08:10PM
Nov 3, 2025 08:10PM
Aug 17, 2025 07:30PM
Jul 10, 2025 09:31AM Ascentage Pharma gets China approval for cancer drug lisaftoclax
Jul 10, 2025 09:30AM
Jul 7, 2025 07:30PM
Jun 15, 2025 07:30PM
Jun 9, 2025 07:30PM
Jun 2, 2025 07:30PM
Jun 2, 2025 07:30PM
May 22, 2025 08:15PM Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025
Apr 21, 2025 07:01AM
Apr 21, 2025 07:00AM
Mar 25, 2025 07:00PM

15,381 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All